期刊文献+

Statin-induced Liver Injury Patterns: A Clinical Review 被引量:3

原文传递
导出
摘要 Since their introduction in 1987,hydroxymethyl glutaryl coenzyme A reductase(HMG-CoA)inhibitors,more commonly known as statins,have become some of the most widely prescribed medications in the world.Though generally considered to be safe and well tolerated,statins have been associated with several side effects including mild liver dysfunction manifested by increases in aminotransferases.Rarely,statins have been noted to induce more serious hepatic injury,including liver injury with autoimmune features.Current literature supports statin induced liver injury presenting in either hepatocellular or cholestatic patterns,though with the former being the prevailing pattern of injury.Fortunately,severe liver injury is uncommon with statin use and is generally reversible without any intervention other than offending statin cessation.When evaluating cases of suspected statininduced liver injury,a complete medical history,laboratory tests including a complete metabolic panel,autoimmune markers,and viral panel,as well as hepatic imaging,are crucial for a complete causality analysis with validated tools such as Roussel Uclaf Causality Assessment Method.The aim of this review is to review the current evidence for statininduced liver injury and cholestasis.
出处 《Journal of Clinical and Translational Hepatology》 SCIE 2022年第3期543-552,共10页 临床与转化肝病杂志(英文版)
  • 相关文献

参考文献3

二级参考文献58

  • 1[1]de Denus S,Spinler SA,Miller K,Peterson AM.Statins and liver toxicity:a meta-analysis.Pharmacotherapy 2004; 24:584-591
  • 2[2]Rosenson RS.Rosuvastatin:a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.Expert Rev Cardiovasc Ther 2003; 1:495-505
  • 3[3]Naranjo CA,Busto U,Sellers EM,Sandor P,Ruiz I,Roberts EA,Janecek E,Domecq C,Greenblatt DJ.A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther 1981; 30:239-245
  • 4[4]Ramos Ramos JC,Sanz Moreno J,Calvo Carrasco L,Garcia Diaz Jde D.Clopidogrel-induced hepatotoxicity.Med Clin (Barc) 2003; 120:156-157
  • 5[5]Duran Quintana JA,Jimenez Saenz M,Montero AR,Gutierrez MH.Clopidogrel probably induced hepatic toxicity.Med Clin (Barc) 2002; 119:37
  • 6[6]Willens HJ.Clopidogrel-induced mixed hepatocellular and cholestatic liver injury.Am J Ther 2000; 7:317-318
  • 7[7]Yeung E,Wong FS,Wanless IR,Shiota K,Guindi M,Joshi S,Gardiner G.Ramipril-associated hepatotoxicity.Arch Pathol Lab Med 2003; 127:1493-1497
  • 8[8]Fry SW,Seeff LB.Hepatotoxicity of analgesics and antiinflammatory agents.Gastroenterol Clin North Am 1995; 24:875-905
  • 9[9]White CM.A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin.J Clin Pharmacol 2002; 42:963-970
  • 10[10]Tornio A,Pasanen MK,Laitila J,Neuvonen PJ,Backman JT.Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.Basic Clin Pharmacol Toxicol 2005; 97:104-108

共引文献25

同被引文献16

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部